Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Isaacs

Showing results (501-510 of 743) with videos related to

Pageof 75
Sort By:
Pharmacogenetics and Genomics|March 6, 2009
Investigation of genetic variants within candidate genes of the TNFRSF1B signalling pathway on the response to anti-TNF agents in a UK cohort of rheumatoid arthritis patientsJohn D Bowes, Catherine Potter, Laura J Gibbons, et al.
Lancet (London, England)|April 17, 2007
Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trialBeatriz Grinsztejn, Bach-Yen Nguyen, Christine Katlama, et al.
Plos One|January 12, 2012
FcγRIIIa expression on monocytes in rheumatoid arthritis: role in immune-complex stimulated TNF production and non-response to methotrexate therapyDawn L Cooper, Stephen G Martin, James I Robinson, et al.
Pharmacogenomics|October 30, 2020
Pharmacogenetics of TNF inhibitor response in rheumatoid arthritis utilizing the two-component disease activity scoreSyed Sa Gilani, Nisha Nair, Darren Plant, et al.
Annals of the Rheumatic Diseases|May 8, 2010
Association between anti-tumour necrosis factor treatment response and genetic variants within the TLR and NF{kappa}B signalling pathwaysCatherine Potter, Heather J Cordell, Anne Barton, et al.
Archives of Disease in Childhood|April 1, 1989
Haemophilus influenzae type b disease in the Oxford regionG Tudor-Williams, J Frankland, D Isaacs, et al.
Rheumatology (Oxford, England)|October 3, 2022
Non-trough adalimumab and certolizumab drug levels associated with a therapeutic EULAR response in adherent patients with rheumatoid arthritisRyan M Hum, Pauline Ho, Nisha Nair, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 11, 2009
A role of cellular prion protein in programming T-cell cytokine responses in diseaseRebecca J Ingram, Jeremy D Isaacs, Gurman Kaur, et al.
Archives of Disease in Childhood|April 1, 1992
Immunogenicity and safety of PRP-T conjugate vaccine given according to the British accelerated immunisation scheduleR Booy, S A Taylor, S R Dobson, et al.
Frontiers in Immunology|June 6, 2018
Phenotypic and Transcriptomic Analysis of Peripheral Blood Plasmacytoid and Conventional Dendritic Cells in Early Drug Naïve Rheumatoid ArthritisFaye A H Cooles, Amy E Anderson, Andrew Skelton, et al.
Pageof 75

Showing results (501-510 of 743) with videos related to

Sort By:
Pageof 75
Pharmacogenetics and Genomics|March 6, 2009
Investigation of genetic variants within candidate genes of the TNFRSF1B signalling pathway on the response to anti-TNF agents in a UK cohort of rheumatoid arthritis patientsJohn D Bowes, Catherine Potter, Laura J Gibbons, et al.
Lancet (London, England)|April 17, 2007
Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trialBeatriz Grinsztejn, Bach-Yen Nguyen, Christine Katlama, et al.
Plos One|January 12, 2012
FcγRIIIa expression on monocytes in rheumatoid arthritis: role in immune-complex stimulated TNF production and non-response to methotrexate therapyDawn L Cooper, Stephen G Martin, James I Robinson, et al.
Pharmacogenomics|October 30, 2020
Pharmacogenetics of TNF inhibitor response in rheumatoid arthritis utilizing the two-component disease activity scoreSyed Sa Gilani, Nisha Nair, Darren Plant, et al.
Annals of the Rheumatic Diseases|May 8, 2010
Association between anti-tumour necrosis factor treatment response and genetic variants within the TLR and NF{kappa}B signalling pathwaysCatherine Potter, Heather J Cordell, Anne Barton, et al.
Archives of Disease in Childhood|April 1, 1989
Haemophilus influenzae type b disease in the Oxford regionG Tudor-Williams, J Frankland, D Isaacs, et al.
Rheumatology (Oxford, England)|October 3, 2022
Non-trough adalimumab and certolizumab drug levels associated with a therapeutic EULAR response in adherent patients with rheumatoid arthritisRyan M Hum, Pauline Ho, Nisha Nair, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 11, 2009
A role of cellular prion protein in programming T-cell cytokine responses in diseaseRebecca J Ingram, Jeremy D Isaacs, Gurman Kaur, et al.
Archives of Disease in Childhood|April 1, 1992
Immunogenicity and safety of PRP-T conjugate vaccine given according to the British accelerated immunisation scheduleR Booy, S A Taylor, S R Dobson, et al.
Frontiers in Immunology|June 6, 2018
Phenotypic and Transcriptomic Analysis of Peripheral Blood Plasmacytoid and Conventional Dendritic Cells in Early Drug Naïve Rheumatoid ArthritisFaye A H Cooles, Amy E Anderson, Andrew Skelton, et al.
Pageof 75